Brett Sandercock - Nov 7, 2022 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Financial Officer
Signature
Brett Sandercock, Chief Financial Officer
Stock symbol
RMD
Transactions as of
Nov 7, 2022
Transactions value $
-$848,068
Form type
4
Date filed
11/9/2022, 04:03 PM
Previous filing
Aug 22, 2022
Next filing
Nov 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale -$848K -4K -3.63% $212.02 106K Nov 7, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $212 to $212.04. The price reported above reflects the weighted average sale price.
F2 Includes 30.50 shares of ResMed stock purchased on October 31, 2022, through the ResMed Employee Stock Purchase Plan.